Ocular drug delivery in veterinary medicine

被引:28
作者
Baeyens, V
Percicot, C
Zignani, M
Deshpande, AA
Kaltsatos, V
Gurny, R [1 ]
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
[2] Ciba Vis Ophthalm, Basel, Switzerland
[3] Vetoquinol, Magny Vernois, F-70204 Lure, France
关键词
ocular drug delivery; veterinary; eye;
D O I
10.1016/S0169-409X(97)00088-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This paper provides a comprehensive overview of the various approaches currently used in the development of ocular drug delivery systems for the treatment of ocular diseases in animals. It is obvious from the literature that most of the products that are currently available are derived from human medicine without consideration given to the differences which exist between the anatomy and physiology of the eye of various animal species which ultimately affect product design and performance. As a result, many of the products for animal use seem in many circumstances inappropriate for animal care. The article deals with some aspects of eye anatomy and physiology of different animals, and then provides an overview of the most commonly encountered pathologies. The paper then discusses the currently available drug products and finally reviews new delivery concepts. Several hundred references are included in the paper and provide access to further information on the subject. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:335 / 361
页数:27
相关论文
共 252 条
[1]  
AGUIRRE GD, 1971, J AM VET MED ASSOC, V158, P1566
[2]   (ACYLOXY)ALKYL CARBAMATES AS NOVEL BIOREVERSIBLE PRODRUGS FOR AMINES - INCREASED PERMEATION THROUGH BIOLOGICAL-MEMBRANES [J].
ALEXANDER, J ;
CARGILL, R ;
MICHELSON, SR ;
SCHWAM, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (02) :318-322
[3]  
ALM A, 1993, OPHTHALMOLOGY, V100, P1312
[4]   Studies on gel tears [J].
Amin, PD ;
Bhogte, CP ;
Deshpande, MA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (07) :735-739
[5]   PATIENT COMPLIANCE WITH USE OF TOPICAL OPHTHALMIC CORTICOSTEROID SUSPENSIONS [J].
APT, L ;
HENRICK, A ;
SILVERMAN, LM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1979, 87 (02) :210-214
[6]  
ARAIZ JJ, 1993, INVEST OPHTH VIS SCI, V34, P522
[7]   EFFICACY OF TOBRAMYCIN-SOAKED COLLAGEN SHIELDS VS TOBRAMYCIN EYEDROP LOADING DOSE FOR SUSTAINED TREATMENT OF EXPERIMENTAL PSEUDOMONAS-AERUGINOSA-INDUCED KERATITIS IN RABBITS [J].
ASSIL, KK ;
ZARNEGAR, SR ;
FOURAKER, BD ;
SCHANZLIN, DJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 113 (04) :418-423
[8]   INVIVO PERFORMANCE OF [H-3] DEXAMETHASONE OPHTHALMIC FILM DELIVERY SYSTEMS IN THE RABBIT EYE [J].
ATTIA, MA ;
KASSEM, MA ;
SAFWAT, SM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 47 (1-3) :21-30
[9]   TOXICITY OF INTRAVITREAL INJECTION OF AMPHOTERICIN-B [J].
AXELROD, AJ ;
PEYMAN, GA ;
APPLE, DJ .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1973, 76 (04) :578-583
[10]   A RAT MODEL OF BACTERIAL KERATITIS - EFFECT OF ANTIBIOTICS AND CORTICOSTEROID [J].
BADENOCH, PR ;
HAY, GJ ;
MCDONALD, PJ ;
COSTER, DJ .
ARCHIVES OF OPHTHALMOLOGY, 1985, 103 (05) :718-722